Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

nintedanib

- PMLiVE

Labour Party takes aim at pharma, calls attention to Orkambi row

Proposal to introduce compulsory licensing faces industry criticism

Programmatic methodology and why you should be using it

What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director

Four Health

- PMLiVE

Boehringer bags FDA OK for Ofev in rare lung disease ILD

First drug approved for condition

- PMLiVE

Prescription drug dependence ‘linked to deprivation’, says PHE

Public Health England publishes review on prescription rates

- PMLiVE

Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit

Additional preparation to ensure continuity of supplies

ABPI Patient Sourcebook

A patient view on the ABPI’s patient collaboration sourcebook

Last month, the ABPI released a much-in-demand document: The Working with Patients and Patient Organisations sourcebook.

Cuttsy + Cuttsy

- PMLiVE

UK pharma’s hard-to-recruit posts need foreign recruitment boost

Post-Brexit immigration policy still unclear

- PMLiVE

Boehringer eyes rare disease use for respiratory blockbuster

Would help support respiratory franchise

- PMLiVE

Novartis and Sanofi heads take on UK pharma leadership roles

Sector must fight for best Brexit outcome

- PMLiVE

Skills shortage and Brexit will hit R&D, warns UK pharma

Skill shortages and Brexit seen as greatest threat

The UK’s new five-year pricing agreement

Pharma has agreed to capped growth again - in exchange for uptake promises

- PMLiVE

NICE appraisal fees to be introduced despite opposition

Concessions made for small companies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links